We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

VIA Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients with Serious Cardiovascular Disease

News   Nov 10, 2008

 
VIA Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients with Serious Cardiovascular Disease
 
 
 

RELATED ARTICLES

Simulations Enable 'Choose-your-own-Adventure' Stereochemistry

News

Stereochemistry is a science of reflection. Two chemical molecules with the same composition and structure, but with one as the mirror image of the other, can produce wildly varying effects. But University of Utah chemist Matt Sigman has been developing a way to get a better grasp on this tricky field of chemistry.

READ MORE

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Better Tailored Drugs with Fewer Side-Effects

News

A recent achievement in the field of protein research allows for better tailored pharmaceuticals with fewer side-effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE